(Q46488287)

22 December 2017

title

Validation of a model to estimate personalised screening frequency to monitor diabetic retinopathy (English)

1 reference

22 December 2017

Sigrún H Lund

5

0 references

Jacqueline M Dekker

10

Jacqueline M Dekker

1 reference

22 December 2017

11

Giel Nijpels

1 reference

22 December 2017

4

Thor Aspelund

1 reference

22 December 2017

Annette C Moll

8

Annette C Moll

1 reference

22 December 2017

Esther van 't Riet

3

Esther van 't Riet

1 reference

22 December 2017

Bettine C. P. Polak

7

Bettine C P Polak

1 reference

22 December 2017

Iris Walraven

2

Iris Walraven

1 reference

22 December 2017

Petra Elders

6

Petra Elders

1 reference

22 December 2017

author name string

Amber A W A van der Heijden

1

1 reference

22 December 2017

Jan E E Keunen

9

1 reference

22 December 2017

publication date

26 April 2014

1 reference

22 December 2017

published in

Diabetologia

1 reference

22 December 2017

volume

57

1 reference

22 December 2017

issue

7

1 reference

22 December 2017

page(s)

1332-1338

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s00125-014-3246-4

exact match

0 references

cites work

Current epidemiology of diabetic retinopathy and diabetic macular edema

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

Biennial eye screening in patients with diabetes without retinopathy: 10-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

The English national screening programme for sight-threatening diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

Identification of independent risk factors for the development of diabetic retinopathy requiring treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

Progression and regression: distinct developmental patterns of diabetic retinopathy in patients with type 2 diabetes treated in the diabetes care system west-friesland, the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

Clinical characteristics influence screening intervals for diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

A simple risk stratification for time to development of sight-threatening diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

The effectiveness of adding cognitive behavioural therapy aimed at changing lifestyle to managed diabetes care for patients with type 2 diabetes: design of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

Interobserver agreement in the interpretation of single-field digital fundus images for diabetic retinopathy screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3246-4

Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study

21 January 2018

1 reference

12 December 2020

Report of the expert committee on the diagnosis and classification of diabetes mellitus

1 reference

12 December 2020

1 reference

12 December 2020

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus

1 reference

12 December 2020

Assessing calibration of prognostic risk scores

1 reference

12 December 2020

Agreement between photographic screening and hospital biomicroscopy grading of diabetic retinopathy and maculopathy

1 reference

12 December 2020

10.1007/S00125-014-3246-4

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

24763851

1 reference

22 December 2017